1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014

Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data on the Generalized Tonic-Clonic Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Tonic-Clonic Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Generalized Tonic-Clonic Seizure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Generalized Tonic-Clonic Seizure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Generalized Tonic-Clonic Seizure 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
UCB S.A. 31
Clinical Trial Overview of UCB S.A. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Johnson and Johnson 33
Clinical Trial Overview of Johnson and Johnson 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
UCB Biosciences GmbH 36
Clinical Trial Overview of UCB Biosciences GmbH 36
SymPhar Sp. z.o.o. 37
Clinical Trial Overview of SymPhar Sp. z.o.o. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Desitin Arzneimittel GmbH 39
Clinical Trial Overview of Desitin Arzneimittel GmbH 39
Alfred E. Tiefenbacher (GmbH and Co. KG) 40
Clinical Trial Overview of Alfred E. Tiefenbacher (GmbH and Co. KG) 40
Clinical Trial Overview of Top Institutes / Government 41
Dutch Epilepsy Clinics Foundation 41
Clinical Trial Overview of Dutch Epilepsy Clinics Foundation 41
Yonsei University 42
Clinical Trial Overview of Yonsei University 42
Emory University 43
Clinical Trial Overview of Emory University 43
Hadassah Medical Organization 44
Clinical Trial Overview of Hadassah Medical Organization 44
Assistance Publique - Hopitaux de Paris 45
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 45
Gillette Children's Specialty Healthcare 46
Clinical Trial Overview of Gillette Children's Specialty Healthcare 46
Five Key Clinical Profiles 47
Appendix 119
Abbreviations 119
Definitions 119
Research Methodology 120
Secondary Research 120
About GlobalData 121
Contact Us 121
Disclaimer 121
Source 121

List of Tables
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Generalized Tonic-Clonic Seizure Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Generalized Tonic-Clonic Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 31
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 33
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 35
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB Biosciences GmbH, 2014* 36
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by SymPhar Sp. z.o.o., 2014* 37
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014* 39
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfred E. Tiefenbacher (GmbH and Co. KG), 2014* 40
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Dutch Epilepsy Clinics Foundation, 2014* 41
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 42
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 43
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 44
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 45
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Gillette Children's Specialty Healthcare, 2014* 46

List of Figures
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Generalized Tonic-Clonic Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Generalized Tonic-Clonic Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Generalized Tonic-Clonic Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Generalized Tonic-Clonic Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Generalized Tonic-Clonic Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Generalized Tonic-Clonic Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 120

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.